+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

Interleukin-1 (IL-1) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin-1 (IL-1) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
Lipodystrophy - Pipeline Insight, 2025 - Product Thumbnail Image

Lipodystrophy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
Diabetic Retinopathy Market - Global Forecast 2025-2032 - Product Thumbnail Image

Diabetic Retinopathy Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 187 Pages
  • Global
From
Retinal Disorder Treatment Market - Global Forecast 2025-2032 - Product Thumbnail Image

Retinal Disorder Treatment Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 193 Pages
  • Global
From
From
From
Choroidal Neovascularization Market - Global Forecast 2025-2032 - Product Thumbnail Image

Choroidal Neovascularization Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 196 Pages
  • Global
From
From
From
Protein Inhibitors Market Report 2025 - Product Thumbnail Image

Protein Inhibitors Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
From
From
Retinal Disorder Treatment Market Report 2025 - Product Thumbnail Image

Retinal Disorder Treatment Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
Loading Indicator